French registry confirms 3-Year results for breathing valve
NCT ID NCT04517916
Summary
This French registry tracked 155 patients with severe emphysema who received the Zephyr Valve treatment. The goal was to collect long-term safety and effectiveness data over three years to support continued availability in France. Doctors followed patients for improvements in breathing and lung volume reduction.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EMPHYSEMA OR COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Arnaud de Villeneuve
Montpellier, France
-
Hôpital Bichat
Paris, France
-
Hôpital Calmette
Lille, France
-
Hôpital Charles Nicolle
Rouen, France
-
Hôpital Cochin
Paris, France
-
Hôpital Dupuytren
Limoges, France
-
Hôpital François Mitterrand
Dijon, France
-
Hôpital La Cavale Blanche
Brest, France
-
Hôpital Larrey
Toulouse, France
-
Hôpital Nord
Latronche, France
-
Hôpital Nord
Saint-Etienne, France
-
Nouvel Hôpital Civil
Strasbourg, France
Conditions
Explore the condition pages connected to this study.